Annalisa Cabriolu

Title: Annalisa Cabriolu: Innovator in Gene Therapy

Introduction

Annalisa Cabriolu is a prominent inventor based in Villacidro, Italy. She has made significant contributions to the field of gene therapy, particularly in the treatment of hemoglobinopathies. Her innovative work has the potential to transform the lives of individuals affected by these genetic disorders.

Latest Patents

Annalisa Cabriolu holds 1 patent for her groundbreaking invention titled "Globin gene therapy for treating hemoglobinopathies." This patent encompasses expression cassettes that facilitate the expression of a globin gene or its functional portions. Additionally, it includes vectors and cells that are transduced with these expression cassettes and vectors. The methods outlined in her patent provide a means for treating hemoglobinopathy in subjects by administering an effective amount of the transduced cells.

Career Highlights

Annalisa Cabriolu is affiliated with the Memorial Sloan Kettering Cancer Center, where she continues her research and development in gene therapy. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Annalisa collaborates with Michel Sadelain, a fellow researcher in the field. Their partnership exemplifies the collaborative spirit that drives innovation in medical research.

Conclusion

Annalisa Cabriolu's contributions to gene therapy highlight her role as a leading inventor in the medical field. Her innovative approaches to treating hemoglobinopathies demonstrate the potential of gene therapy to change lives.